Parliament strengthens public health slant on EU pharma proposals
This article was originally published in SRA
Executive Summary
The European Parliament’s rapporteurs for the draft European Union legislation on pharmacovigilance and counterfeit medicines have amended the proposals to put more emphasis on the need to ensure the protection of public health.